Middle East Diabetes Devices and Therapeutics Market
Dublin, July 01, 2025 (GLOBE NEWSWIRE) -- The "Middle East Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update" report has been added to offering.
The diabetes market in Middle East is expected to grow by 9.2% on annual basis to reach US$5.45 billion in 2025. The diabetes market in the region has experienced robust growth during 2020-2024, achieving a CAGR of 9.9%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.6% during 2025-2029. By the end of 2029, the diabetes market is projected to expand from its 2024 value of USD 4.99 billion to approximately USD 7.96 billion.
The Middle Eastern diabetes devices and therapeutics market is being shaped by national diabetes screening initiatives, integration of digital health tools, regional manufacturing investments, and expanding public-private partnerships. These trends are expected to intensify over the next 2-4 years, leading to improved patient identification, technology-driven care delivery, and more competitive regional production capacity.
The Middle Eastern diabetes devices and therapeutics market is a mix of multinational leadership, growing regional players, and public-private alliances. Ongoing localization efforts and digital innovation are reshaping the competitive environment, with increased consolidation and regional supply chain integration expected in the coming years.
Diabetes Devices and Therapeutics Market Share by Route of Administration
- Others
Diabetes Devices and Therapeutics Market Share by Type of Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
Diabetes Devices and Therapeutics Market Share by Distribution Channels
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Diabetes Devices and Therapeutics Market Share by End User
- Hospitals
- Diabetes Clinics
- Homecare
- Comprehensive understanding of market structure and dynamics: Gain a detailed view of the diabetes devices and therapeutics market, including category-level segmentation (Diagnosis & Monitoring Devices and Therapeutics) and sub-segmentation by product type, route of administration, type of diabetes, distribution channel, and end user.
- Identify high-growth segments and strategic investment areas: Use segment-wise market sizing and forecasting to identify opportunities in areas such as continuous glucose monitoring, insulin delivery technologies, oral anti-diabetic drugs, and biosimilars. Tailor your market entry or expansion strategies accordingly.
- Benchmark performance across distribution and care settings: Access share analysis across online, hospital, and retail pharmacies, and evaluate usage patterns across hospitals, diabetes clinics, and homecare to support channel-specific planning and resource allocation.
| Report Attribute | Details |
| No. of Pages | 260 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value (USD) in 2025 | $5.92 Billion |
| Forecasted Market Value (USD) by 2029 | $7.96 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Middle East |
For more information about this report visit https://www.researchandmarkets.com/r/txpq67
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
